2016至2019年中国严重产后出血发生率及趋势
该研究基于国家医疗质量抽样调查数据,纳入2016至2019年分别为2 978、3 400、4 576和4 594家助产机构,分析严重产后出血发生率。全国发生率从2016年0.62%升至2018年0.93%,2019年为0.92%。双胎分娩率、巨大儿发生率、高龄产妇比例和初产妇比例与发生率正相关(P均<0.05)。
要点
- 2016至2018年全国严重产后出血发生率上升,2019年略降至0.92%。
- 2019年发生率最高为云南1.88%,最低为河南0.55%。
- 三级公立综合医院发生率最高(1.15%),二级公立专科医院最低(0.58%)。
核心结论
- 我国严重产后出血发生率2016年后总体呈上升趋势,近两年趋于平稳但仍处于较高水平。
- 需继续加强产后出血监测,提高助产机构和地区危重孕产妇分级管理和救治能力。
研究设计与样本
- 基于国家医疗质量管理与控制信息网全国医疗质量抽样调查的产科数据。
- 纳入2016至2019年各年有严重产后出血(出血量≥1 000 ml)病例的助产机构,分别为2 978、3 400、4 576和4 594家。
- 采用广义线性模型分析严重产后出血发生的影响因素。
主要发现
- 18个省市自治区呈先升后降趋势,10个持续上升,3个先降后升。
- 2019年发生率最高的5个省市自治区:云南1.88%、北京1.45%、江苏1.31%、贵州1.26%、宁夏1.22%。
- 2019年发生率最低的5个省市自治区:河南0.55%、江西0.60%、内蒙古0.64%、辽宁0.64%、甘肃0.69%。
- 2019年各类助产机构发生率:三级公立综合医院1.15%、三级公立专科医院1.02%、二级公立综合医院0.81%、民营医院0.61%、二级公立专科医院0.58%。
关键数值与推荐
- 严重产后出血定义为产后出血量≥1 000 ml。
- 助产机构的双胎分娩率、巨大儿发生率、高龄产妇比例和初产妇比例与严重产后出血发生率显著正相关(P均<0.05)。
临床怎么用
- 应加强产后出血监测,关注双胎、巨大儿、高龄和初产妇等高危因素。
- 提高助产机构和地区危重孕产妇分级管理和救治能力,以降低严重产后出血和孕产妇死亡。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the incidence and trend of severe postpartum hemorrhage (sPPH) in China, and to provide basic data for the development and evaluation of sPPH prevention and control strategy. Methods: Obstetric data was extracted from annual national representative sampling surveys based on the National Clinical Improvement System. From 2016 to 2019, 2 978, 3 400, 4 576 and 4 594 maternity hospitals with sPPH cases were included for statistics. The annual incidence of sPPH was calculated according to province and type of medical institutions and generalized linear model was emplyed to identify the determinants affecting sPPH incidence. Results: In China, sPPH incidence increased from 0.62% in 2016 to 0.93% in 2018, and was 0.92% in 2019. Eighteen provinces had an inverted U-shaped trend of sPPH over time and most of them had the highest incidence in 2018; ten provinces had an upward trend of sPPH and 3 provinces had a U-shaped trend. In 2019, the top five provinces with the highest sPPH incidence were Yunnan (1.88%), Beijing (1.45%), Jiangsu (1.31%), Guizhou (1.26%), and Ningxia Hui Autonomous Region (1.22%); the top five provinces with the lowest incidence were Henan (0.55%), Jiangxi (0.60%), Inner Mongolia Autonomous Region (0.64%), Liaoning (0.64%) and Gansu (0.69%). In 2019, the sPPH incidence in different types of medical institutions were as follows: tertiary public general hospital (1.15%), tertiary public specialized hospital (1.02%), secondary public general hospital (0.81%), private hospital (0.61%) and secondary public specialized hospital (0.58%). sPPH incidence was positively associated with proportion of twin pregnancies, macrosomia, primipara, and puerpera aged ≥35 years in maternity hospitals (P<0.05). Conclusions: sPPH incidence generally showes an increasing trend from 2016 and is stable at a high level in recent two years in China. It is warranted to further strengthen the monitoring of postpartum hemorrhage, and improve the capability of hierarchical management and treatment in maternity institutions and regions, in order to reduce sPPH incidence and maternal mortality. 目的: 分析中国严重产后出血的流行现状和变化趋势,为产后出血防控措施的制定和评估提供数据支持。 方法: 本研究的数据来源于国家医疗质量管理与控制信息网全国医疗质量抽样调查上报的各助产机构的产科数据。纳入统计了2016—2019年各年产后出血量≥1 000 ml发生例数的助产机构,分别为2 978、3 400、4 576、4 594家,计算全国、各省市自治区、各类别助产机构每年严重产后出血的发生率。采用广义线性模型,分析严重产后出血发生的影响因素。 结果: 2016—2018年全国严重产后出血发生率呈上升趋势,分别为0.62%、0.81%、0.93%,2019年略有下降,为0.92%。全国有18个省市自治区严重产后出血发生率先升后降,发生率最高多为2018年;另有10个省市自治区为持续上升型,3个省市自治区为先降后升型。2019年全国严重产后出血发生率最高的5个省市自治区依次为云南(1.88%)、北京(1.45%)、江苏(1.31%)、贵州(1.26%)、宁夏回族自治区(1.22%),最低的5个省市自治区依次为河南(0.55%)、江西(0.60%)、内蒙古自治区(0.64%)、辽宁(0.64%)和甘肃(0.69%)。2019年各类别助产机构严重产后出血发生率从高到低依次为:三级公立综合医院(1.15%)、三级公立专科医院(1.02%)、二级公立综合医院(0.81%)、民营医院(0.61%)和二级公立专科医院(0.58%)。助产机构的双胎分娩率、巨大儿发生率、高龄产妇比例和初产妇比例与严重产后出血发生率显著正相关(P均<0.05)。 结论: 我国严重产后出血发生率在2016年后总体呈上升趋势,近两年趋于平稳但仍处于较高水平。未来需继续加强产后出血的监测,并提高助产机构和地区危重孕产妇分级管理和救治能力,以减少孕产妇严重产后出血和死亡的发生。.
引用
- Shi HF, Chen L, Wang XX, et al. [Incidence and trend of severe postpartum hemorrhage between 2016 and 2019 in China]. Zhonghua Fu Chan Ke Za Zhi. 2021. PMID: 34304436. doi:10.3760/cma.j.cn112141-20210209-00070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。